3 ms·
How does pharma decide to stake billions on something? I'm thinking of Biogen and Aduhelm, but in total tens of billions have been spent investigating Alzheimer
by jeffbee 5y ago
How does pharma decide to stake billions on something? I'm thinking of Biogen and Aduhelm, but in total tens of billions have been spent investigating Alzheimer's treatments that don't work. How did they decide to pursue those dead ends?
- sjg007 5y agoTotal addressable market and people willing to pay. But a lot of what they do is outsource the initial R&D. First, however you have to have a promising pre-clinical studies, then likely pass a Phase-1 trial. Lots of bio startups take a pre-clinical product through a Phase-1 trial. Traditionally, they would IPO to fund this. That game has changed a bit, where now some VCs will sponsor the Phase 1. There's also the whole SPAC thing as well. If Phase-1 is a success they usually get bought by a big biotech or pharma.